Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Evotec AG
Evotec and Almirall Enter into a Multi-Target Alliance in Medical Dermatology
May 19, 2022
From
Evotec AG
Via
AccessWire
Tickers
EVO
EVOTF
Evotec and Sernova Announce Exclusive Strategic Partnership for iPSC-based Beta Cell Replacement Therapy to Advance a 'Functional Cure' for Diabetes
May 17, 2022
From
Evotec AG
Via
AccessWire
Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership
May 10, 2022
From
Evotec AG
Via
AccessWire
Tickers
EVO
Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership in Protein Degradation
May 10, 2022
From
Evotec AG
Via
AccessWire
Tickers
EVO
Evotec SE to Announce Results for the First Quarter 2022 on 11 May 2022
May 04, 2022
From
Evotec AG
Via
AccessWire
Tickers
EVO
Evotec SE Fiscal Year 2021 Results: 'Setting the Pace' on the Data-Driven R&D Autobahn to Cures
April 12, 2022
From
Evotec AG
Via
AccessWire
Tickers
EVO
EVOTF
Evotec Achieves Programme Designation in Neuroscience Collaboration with Bristol Myers Squibb
April 08, 2022
From
Evotec AG
Via
AccessWire
Tickers
EVO
EVOTF
Evotec SE to Announce Results for Fiscal Year 2021 on 12 April 2022
April 05, 2022
From
Evotec AG
Via
AccessWire
Tickers
EVO
Evotec Receives € 3 m Milestone Payment for Bayer Starting Phase II Clinical Development of DNP Programme
March 21, 2022
From
Evotec AG
Via
AccessWire
Tickers
EVO
Evotec Presents Strategic Roadmap Towards Precision Medicine and Confirms Goals of Action Plan 2025 at Capital Markets Day
March 02, 2022
From
Evotec AG
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Tickers
EVO
Evotec Expands Molecular Patient Database with Unique Nephrotic Syndrome Cohort from the University of Bristol
March 01, 2022
From
Evotec AG
Via
AccessWire
Tickers
EVO
Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to all P2X3 Assets
February 04, 2022
From
Evotec AG
Via
AccessWire
Tickers
EVO
Evotec Enters iPSC-based Drug Discovery Partnership with Boehringer Ingelheim in Ophthalmology
January 25, 2022
From
Evotec AG
Via
AccessWire
Tickers
EVO
Evotec and Lilly Enter into Drug Discovery Collaboration in Metabolic Diseases
January 18, 2022
From
Evotec AG
Via
AccessWire
Tickers
EVO
Evotec Expands Neuroscience Collaboration with Bristol Myers Squibb to Include New Targeted Protein Degradation Approach
January 11, 2022
From
Evotec AG
Via
AccessWire
Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic
January 03, 2022
From
Evotec AG
Via
AccessWire
Exposures
COVID-19
Tickers
EVO
EVOTF
Evotec Receives US$ 18 M Grant for Women's Health
December 16, 2021
From
Evotec AG
Via
AccessWire
Evotec and EQRx Announce Integrated Drug Discovery and Development Partnership
November 18, 2021
From
Evotec AG
Via
AccessWire
Tickers
EVO
Evotec SE Reports Results for the First Nine Months 2021 and Provides Corporate Update
November 11, 2021
From
Evotec AG
Via
AccessWire
Topics
Initial Public Offering
Exposures
COVID-19
Securities Market
Evotec Reaches Programme Designations in Neuroscience Collaboration with Bristol Myers Squibb
November 10, 2021
From
Evotec AG
Via
AccessWire
Exposures
Product Safety
Tickers
EVO
Evotec SE Announces Closing of Public Offering
November 09, 2021
From
Evotec AG
Via
AccessWire
Tickers
EVO
Evotec SE Announces Placement of Its Public Offering of American Depositary Shares
November 03, 2021
From
Evotec AG
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Evotec SE To Announce Results for the First Nine Months 2021 On 11 November 2021
November 03, 2021
From
Evotec AG
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Evotec SE: Announces Launch of Public Offering of American Depositary Shares
October 26, 2021
From
Evotec AG
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Evotec Provides Preliminary Nine Month Financial Results
October 26, 2021
From
Evotec AG
Via
AccessWire
Evotec SE files Registration Statement for Proposed Offering of American Depositary Shares
October 11, 2021
From
Evotec AG
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Evotec Expands Neuroscience Collaboration with Bristol Myers Squibb to Include Novel Cell Type
October 08, 2021
From
Evotec AG
Via
AccessWire
Evotec Announces Bristol Myers Squibb Opt-in of EVT8683 as the First Programme from iPSC-based Neurodegeneration Collaboration
September 02, 2021
From
Evotec AG
Via
AccessWire
Exposures
Product Safety
Just - Evotec Biologics Opens J.POD 1 US in Redmond, Washington
August 11, 2021
From
Evotec AG
Via
AccessWire
Exposures
COVID-19
Evotec SE Reports First Half-Year 2021 Results and Corporate Updates
August 11, 2021
From
Evotec AG
Via
AccessWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.